Accès gratuit
Med Sci (Paris)
Volume 29, Numéro 12, Décembre 2013
Page(s) 1074 - 1076
Section Nouvelles
Publié en ligne 20 décembre 2013
  1. Mellor RH, Hubert CE, Stanton AW, et al. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation 2010 ; 17 : 281–296. [CrossRef] [PubMed]
  2. Petrova TV, Karpanen T, Norrmen C, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004 ; 10 : 974–981. [CrossRef] [PubMed]
  3. Mellor RH, Brice G, Stanton AW, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation 2007 ; 115 : 1912–1920. [CrossRef] [PubMed]
  4. Bazigou E, Lyons OT, Smith A, et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest 2011 ; 121 : 2984–2992. [CrossRef] [PubMed]
  5. Norrmen C, Ivanov KI, Cheng J, et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 2009 ; 185 : 439–457. [CrossRef] [PubMed]
  6. Sabine A, Agalarov Y, Maby-El Hajjami H, et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell 2012 ; 22 : 430–445. [CrossRef] [PubMed]
  7. Tatin F, Taddei A, Weston A, et al. Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev Cell 2013 ; 26 : 31–44. [CrossRef] [PubMed]
  8. Bazigou E, Xie S, Chen C, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 2009 ; 17 : 175–186. [CrossRef] [PubMed]
  9. Kanady JD, Dellinger MT, Munger SJ, et al. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 2011 ; 354 : 253–266. [CrossRef] [PubMed]
  10. Makinen T, Adams RH, Bailey J, et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005 ; 19 : 397–410. [CrossRef] [PubMed]
  11. Levet S, Ciais D, Merdzhanova G, et al. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood 2013 ; 122 : 598–607. [CrossRef] [PubMed]
  12. Bouvree K, Brunet I, Del Toro R, et al. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ Res 2012 ; 111 : 437–445. [CrossRef] [PubMed]
  13. Jurisic G, Maby-El Hajjami H, Karaman S, et al. An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ Res 2012 ; 111 : 426–436. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.